University of Texas M.D. Anderson Cancer Centers Proton Therapy Center.


January 13, 2010 – There is growing awareness about the advantages of proton therapy compared to conventional photon radiation therapy, especially when treating pediatric patients. Protons release most of their energy when they hit the tumor and deliver no exit dose beyond the tumor boundary, unlike photons. This enables the dose to better conform to the tumor and minimizes damage to healthy surrounding tissue, and enabling the radiation oncologist can potentially deliver an even greater dose. This less damaging deliver of dos is especially important when treating children by reducing radiation to growing and developing tissues.

As the proton therapy becomes more prevalent, the first proton-certified radiation therapists (RTTs) in the U.S. received advanced proton therapy certificates was notable. The RTTs earned their certificates at the Ivy Tech Community College-Bloomington program, which provides 16 college credits or the equivalent of two years of continuing education (CE) credits from the American Registry of Radiologic Technologists (ARRT). A portion of the program was held at the ProCure Training and Development Center in Bloomington, a training facility dedicated to proton therapy.

More specialized training in the field will be needed as more proton therapy spring up. Procure, a proton therapy center development company, is currently building a network of proton therapy treatment facilities across the United States. Construction is under way on a ProCure facility in suburban Chicago. Additional centers are in development in suburban Detroit, Mich., South Florida, Seattle, Wash., and Somerset, N.J.

For more information: www.ivytech.edu/bloomington and www.procure.com


Related Content

News | Artificial Intelligence

May 14, 2024 — Elekta announced the launch of its latest linear accelerator (linac), Evo*, a CT-Linac with new high ...

Time May 14, 2024
arrow
News | Radiation Oncology

May 10, 2024 — Mariana Oncology, a fully integrated biotechnology company pioneering a new era of radiopharmaceutical ...

Time May 10, 2024
arrow
News | Radiation Oncology

May 10, 2024 — Insurance expansions under the Affordable Care Act (ACA) were linked with an increase in patients ...

Time May 10, 2024
arrow
News | Treatment Planning

May 6, 2024 — Elekta announced the acquisition of Philips Healthcare’s Pinnacle Treatment Planning System (TPS) patent ...

Time May 06, 2024
arrow
News | Artificial Intelligence

May 2, 2024 — Radformation, Inc., a leader in automation solutions for cancer care, announced today that it has acquired ...

Time May 02, 2024
arrow
News | Prostate Cancer

May 2, 2024 — GT Medical Technologies, Inc. (GT MedTech), a medical device company with the mission of improving the ...

Time May 02, 2024
arrow
News | FDA

April 29, 2024 — The U.S. Food and Drug Administration (FDA) announced Elekta Instrument AB is recalling Disposable ...

Time April 29, 2024
arrow
News | Radiation Dose Management

April 25, 2024 — BIOTRONIK, a leading global medical technology company specializing in innovative cardiovascular and ...

Time April 25, 2024
arrow
News | Artificial Intelligence

March 28, 2024 — As artificial intelligence (AI) makes its way into cancer care – and into discussions between ...

Time March 28, 2024
arrow
News | Prostate Cancer

March 27, 2024 — A minimally invasive treatment using MRI and transurethral ultrasound instead of surgery or radiation ...

Time March 27, 2024
arrow
Subscribe Now